Ginkgo bioworks announces participation in ubs medtech, tools and genomics summit 2023

Boston , aug. 10, 2023 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna, "ginkgo"), which is building the leading platform for cell programming and biosecurity, announced today that management is scheduled to participate in a panel discussion titled "generative ai & innovation across drug discovery, molecule synthesis, & precision medicine" at the ubs medtech, tools and genomics summit 2023 on tuesday, august 15 at 2:00 p.m. pacific time.
DNA Ratings Summary
DNA Quant Ranking